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Coxsackievirus B3 (CVB3) is nonenveloped and has a single-stranded positive-sense RNA genome. CVB3 induces myocarditis and
ultimately dilated cardiomyopathy. Although there are mounting evidences of an interaction between CVB3 particles and the cellular
receptors, coxsackievirus and adenovirus receptor (CAR) and decay-accelerating factor (DAF), very little is known about the mechanisms of
internalization and trafficking. In the present study, we used the CVB3 H3 strain, which is CAR-dependent but DAF-independent Woodruff
variant and found that during entry, CVB3 particles were colocalized in clathrin, after interacting primarily with CAR, which was not
recycled to the plasma membrane. We also found that CVB3 internalization was dependent on the function of dynamin, a large GTPase that
has an essential role in endocytosis. Heat-shock cognate protein, Hsc70, which acts as a chaperone in the release of coat proteins from
clathrin-coated vesicles (CCV), played a role in CVB3 trafficking processes. Moreover, endosomal acidification was crucial for CVB3
endocytosis. Finally, CVB3 was colocalized in early endosome autoantigen 1 (EEA1) molecules, which are involved in endosome–endosome
tethering and fusion. In conclusion, these data together indicate that CVB3 uses clathrin-mediated endocytosis and is transcytosed to early
endosomes.
D 2004 Elsevier Inc. All rights reserved.
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Initial entry of the viral genome and accessory proteins
across the plasma membrane and into the cytoplasm of host
cells is required to achieve the final goal of viral life to
produce progeny by replication and the expression of viral
genes. Most viruses use one of two principal methods of
internalization. In the first, viruses deliver their genomes
into the cytoplasm by direct penetration across the plasma
membrane. In the second, the virus itself is invaginated into
the cytoplasm by endocytosis using cellular compartments,0042-6822/$ - see front matter D 2004 Elsevier Inc. All rights reserved.
doi:10.1016/j.virol.2004.12.010
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E-mail address: jnam66@yahoo.com (J.-H. Nam).such as clathrin-coated vesicles (CCV) or caveolae (Pelk-
mans and Helenius, 2003; Sieczkarski and Whittaker, 2002).
Many animal viruses utilize receptor-mediated endocytosis
because it has several advantages over the alternative
strategy, such as an increase in the efficiency of viral
binding to cellular surfaces and a decreased risk of
immunodetection (Marsh and Helenius, 1989; Pelkmans
and Helenius, 2003).
The entry routes of some viruses have been characterized
by observation under electron microscopy (EM), treatment
with pharmacological inhibitors of specific entry routes, and
the use of dominant-negative mutant proteins involved in
specific entry mechanisms (Feig, 1999; Sieczkarski and
Whittaker, 2002). Using these methods, it has been
established that influenza virus, adenovirus, human poly-005) 31–40
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virus, Sindbis virus, and human rhinovirus 14 require active
clathrin-mediated endocytosis for infection, whereas simian
virus 40 and mouse polyomavirus use caveolae-mediated
endocytosis (Anderson et al., 1996; DeTulleo and Kirch-
hausen, 1998; Marsh and Helenius, 1980, 1989; Pho et al.,
2000; Superti et al., 1987). More recently, it has been
reported that the entry of human papillomavirus (HPV)-16
and HPV-58 involves clathrin-mediated endocytosis,
whereas HPV-31 uses caveolae-mediated endocytosis for
infection (Bousarghin et al., 2003). It suggests that even
strains of the same viral species use different endocytotic
mechanisms.
After viruses are entered into the cytoplasm, the
internalized viruses use general cell trafficking systems in
postendocytic pathways. Therefore, it is reasonable to
expect that some cellular factors that play a role in
intracellular trafficking may affect viral trafficking. Dyna-
min, a large GTPase of ~100 kDa, controls the scission
reaction that facilitates the budding of invaginated pits from
the plasma membrane, which subsequently leads to the
formation of clathrin-coated vesicles (CCV), as well as
caveolae (Damke et al., 1994; Oh et al., 1998; Sever et al.,
2000). Therefore, mutant dynamin confers GTPase defi-
ciency, which specifically blocks endocytosis (Feig, 1999).
After the release of coated vesicles, the heat-shock cognate
protein, Hsc70, is necessary for the disassembly of the coat
protein from the CCV (CCV uncoating process) (Chang et
al., 2002; Newmyer and Schmid, 2001; Newmyer et al.,
2003). Another important factor for endocytosis is the low-
pH-dependent conformational changes that occur within
endosomal compartments, which are required for the
internalization, uncoating, and trafficking of many viruses.
These viruses require a low pH in the intracellular environ-
ment for their release from the endocytic pathway into the
host cytoplasm (Marsh and Helenius, 1989; Nicola et al.,
2003; Sieczkarski and Whittaker, 2002).
Coxsackievirus B3 (CVB3) is a member of the entero-
virus genus of the family Picornaviridae. CVB3 is non-
enveloped and has a single-stranded positive-sense RNA
genome. This virus induces viral myocarditis and ultimately
dilated cardiomyopathy (Knowlton and Badorff, 1999). The
cellular receptors of CVB3 are known as the coxsackievirus
and adenovirus receptor (CAR) and the decay-accelerating
factor (DAF; CD55). CAR, in particular, is a major entry
receptor for the primary internalization of CVB3, and DAF
is a regulatory and attachment protein that acts as a co-
receptor (Carson, 2001; Tomko et al., 1997). Previous
studies have reported the initial interactions between CVB3
particles and cell-surface receptors (He et al., 2001; Shieh
and Bergelson, 2002). However, very little is known of the
internalization mechanism or the postendocytotic pathway
during or after entry of CVB3.
In the present study, we examined the internalization and
trafficking pathway of CVB3 (H3, Woodruff variant) during
and after infection. We used several methods, to obviate anyambiguity arising from the method of analysis and to
confirm the data of each individual method, which included
visual techniques such as confocal microscopy and EM, and
the use of mutant proteins or chemical inhibitors relevant to
endocytosis. We found that CVB3 interacted initially with
CAR, which was not recycled to the plasma membrane.
CVB3 also colocalizes with clathrin during entry. Moreover,
the use of mutant dynamin and the down-regulation of
Hsc70 prevented CVB3 endocytosis in infected HeLa cells.
In addition, CVB3 transcytosed to early endosome. The
findings described above strongly imply that CVB3 uses
CAR in receptor-mediated internalization and clathrin-
dependent endocytosis, and that intact endosomal function
is necessary for the intracellular trafficking pathway of
CVB3.Results
CVB3 uses CAR as receptor for entry into HeLa cells
Here we used the CVB3 H3 strain of the Woodruff
variant for viral infection (referred to herein as CVB3).
Although CAR and DAF are known to function as CVB3
receptors, the role of these receptors in CVB3 entry has not
been clear. To determine whether anti-CAR or DAF
antibodies block CVB3 infection, these antibodies of
various dilutions were incubated with cells before CVB3
infection. The blocking of CVB3 infection was clearly
dependent on the concentration of anti-CAR, but not anti-
DAF (Fig. 1A). Interestingly, anti-DAF-incubated cells also
showed partially blocked CVB3 infection (Fig. 1A).
Furthermore, only CHO cells expressing CAR could be
infected with CVB3, which represented VP1 expression, but
not in DAF-expressed CHO cells (Fig. 1B). It means that
CAR is major route for CVB3 entry. These results are
consistent with previous data (Hsu et al., 1988; Bergelson et
al., 1997; Schmidtke et al., 2000). After 30 min or 3.5 h of
CVB3 infection, anti-CAR or anti-DAF antibodies were
incubated with the cells and detected by flow cytometry
(FACS) analysis to calculate the amount of CAR or DAF
remaining on the cell surface. FACS analysis showed that
CAR was dramatically diminished at 30 min postinfection
(pi) and had not recovered by 3.5 h pi, whereas the
distribution of DAF did not change at either time point (Fig.
1C). This suggests that CVB3 interacts predominantly with
CAR at the cell surface during entry, after which CAR is
internalized, but not DAF, with the CVB3 particle. CAR is
degraded after internalization and is not recycled to the
plasma membrane.
Invaginated CVB3 particles are localized to clathrin-coated
vesicles
If CVB3 uses an endocytotic mechanism to infect HeLa
cells, it is possible that CVB3 particles are internalized in
Fig. 1. CVB3 uses CAR as receptor for entry. (A) The effects of blocking CAR or DAF on CVB3 infection. The serial dilution of antibodies to CAR (RmcB,
0.2–4 Ag/ml) or DAF (mAb DAF, 0.1–4 Ag/ml) were incubated with HeLa cells for 1 h before CVB3 infection. IgG was used for the negative control. At 4 h
postinfection (pi), cells were harvested to detect the expression of the CVB3 protein, VP1, with anti-VP1 antibody (dilution 1:1000). Tubulin was used as an
internal control. (B) CHO cells were transiently expressed CAR or DAF after 24 h transfection of recombinant plasmids (pcDNA3.1) containing CAR or DAF
genes following CMV promoter and infected with CVB3. At 6 h pi, cells were harvested to detect the expression of VP1. (C) Flow-cytometric analysis of CAR
and DAF on HeLa cells infected with CVB3 or control HeLa cells without infection at 30 min and 3.5 h pi. The dotted line represents the amount of CAR or
DAF on the surfaces of control HeLa cells. The thick line indicates the amount of CAR or DAF on the surfaces of CVB3-infected HeLa cells. The thin line
shows the autofluorescent control treated with IgG.
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examined this possibility using confocal microscopy with an
FITC-conjugated monoclonal antibody directed against the
viral protein VP1, which is the major external structural
protein (visualized as green) and Alexa-Fluor-594-conju-
gated antibodies directed against clathrin or caveolin, which
is abundantly present in caveolae (visualized as red). To
increase the possibility of detecting the viral protein VP1 byFig. 2. Internalized CVB3 particles occur in clathrin-coated vesicles. (A) The colo
image, which are indicated by arrowheads. CVB3 protein VP1 is stained with an
Clathrin is stained with anti-clathrin heavy-chain antibody and Alexa-Fluor-59
indicated by arrows) and caveolin-1 (Alexa-Fluor-594 labeled red, indicated by a
Electron microscopic analysis of CVB3 uptake into HeLa cells. The section is imm
indicate a forming clathrin-coated pit (CCP) with CVB3. Arrowhead on the rightfluorescence, we infected at a high CVB3 moi (N100) (Fig.
2). At 10 and 20 min pi, viral protein VP1 colocalized with
clathrin (Fig. 2A, represented by arrowheads), but not with
caveolin (Fig. 2B). Caveolin did not colocalize with VP1
even at 60 min pi (data not shown). Moreover, the
distribution of caveolin was clearly different from that of
VP1 (Fig. 2B, arrowheads represent caveolin and arrows
represent VP1).calization of VP1 and clathrin is represented by yellow spots in the merged
ti-VP1 antibody and FITC-labeled secondary antibody (small green spots).
4-labeled secondary antibody (red spots). (B) VP1 (FITC labeled green,
rrowheads) present in caveolae do not colocalize in the merged image. (C)
unostained with anti-clathrin antibody. Arrowheads on the left and middle
represents invaginated CVB3 particles in a clathrin-coated vesicle (CCV).
Fig. 3. Dynamin and Hsc70 proteins are critical to CVB3 endocytosis. (A)
Effect of dynamin on CVB3 infection of HeLa cells. Four hours after CVB3
infection of sham-infected, wild-type (expressing wild-type dynamin), and
K44A (expressing mutant dynamin) HeLa cells, the cells were harvested
and the level of VP1 expression determined as an index of the efficiency of
CVB3 infection. All cells were cultured in tetracycline-deficient medium to
induce wild-type or mutant dynamin. (B) Effects of hsc70 siRNA on HeLa
cells. Plasmid encoding hsc70 siRNA or siRNA empty vector (for details,
see Materials and methods) was transfected into cells, and transfectants
were selected with hygromycin to produce stable cell lines. hsc70 mRNA
levels were detected by RT–PCR. HeLa cells transfected with siRNA empty
vector were used as controls. GAPDH was used as the internal RNA
control. (C) Hsc70 effect on CVB3 infection. Hsc70–HeLa cells are HeLa
cells with reduced levels of hsc70 mRNA generated with siRNA. At 4 h pi
with CVB3, cells were harvested and the levels of VP1 expression
determined as an index of the efficiency of CVB3 infection. Tubulin was
used as an internal control.
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strated the colocalization of CVB3 particles and clathrin, we
used immunoelectron microscopy staining for clathrin.
CVB3-infected cells were incubated for 5 and 15 min pi
before fixation. At 5 min pi, some CVB3 particles were
bound to newly forming clathrin-coated pits (CCP) (Fig. 2C
left and middle, represented by arrowheads). At 15 min pi,
viral particles were present in CCV (Fig. 2C right,
represented by arrowhead). Although there are some
limitations to the interpretation of EM data, such as
sectioning artifacts and the rapid removal of clathrin coats
upon endocytosis (Ashbourne Excoffon et al., 2003), the
results of confocal microscopy and EM clearly suggest that
the internalization of CVB3 across the plasma membrane
occurs via a clathrin-mediated mechanism.
Dynamin is necessary for CVB3 endocytosis
Dynamin, a large GTPase, is apparently required in
clathrin- or caveolae-mediated endocytosis (Damke et al.,
1994; Oh et al., 1998). This protein regulates the fission
reaction that forms vesicles from the plasma membrane
and also plays a role in the actin-mediated transport of
endocytic vesicles via a GTP-dependent mechanism (Jin et
al., 2002; Lee and De Camilli, 2002; Sever et al., 2000). A
dynamin mutant, K44A, is defective in GTP binding and
blocks endocytosis (DeTulleo and Kirchhausen, 1998; Jin
et al., 2002). In this study, we used two types of HeLa
cells that had been stably transfected with either wild-type
or dominant-negative (K44A) dynamin controlled by a
tetracycline-inducible promoter. Both types of HeLa cells
expressed dynamin during incubation in tetracycline-
deficient medium. After 2 days incubation in tetracy-
cline-deficient medium, cells were infected with CVB3. At
4 h pi, infected cells were harvested and analyzed by
Western blots probed with anti-VP1 antibody to measure
the infectivity of CVB3 in both cell types. We confirmed
that the expression of VP1 is well represented the virus
titer, which is achieved by plaque assay (data not shown).
Therefore, we used the expression of VP1 as index of the
infectivity of CVB3 in this study. We found that the
infectivity of CVB3 in K44A-transfected cells was reduced
compared with that of HeLa cells expressing wild-type
dynamin (Fig. 3A). K44A did not completely block CVB3
infection because K44A was not expressed in 40–60% of
cells, which is supported by a previous report (Jin et al.,
2002). About half the K44A-transfected cells expressed
wild-type dynamin, so CVB3 could infect these cells.
Therefore, a 60–70% reduction in infectivity is sufficient
to imply that the infection of CVB3 is dependent on
dynamin-regulated endocytosis.
Hsc70 is involved in CVB3 trafficking
There are mounting evidences that Hsc70 regulates coat
disassembly and the multiple transport and sorting eventsbetween endosomal compartments, in that Hsc70 broadly
modulates clathrin dynamics throughout the CCV cycle
(Chang et al., 2002; Newmyer and Schmid, 2001; Newmyer
et al., 2003). Moreover, it was previously reported that
antibodies against Hsc70 interfered with receptor-mediated
endocytosis (Honing et al., 1994). Therefore, if Hsc70 has a
role in CVB3 endocytosis, it means that invaginated CVB3
particles are related with CCV. Therefore, we explored
whether Hsc70 is necessary for CVB3 endocytosis. Firstly,
Fig. 4. Low pH in cellular organelles is critical for CVB3 infection. HeLa
cells were treated with 50 mM of NH4Cl for 30 min before CVB3 infection
(moi = 10). (A) Distribution and expression of CVB3 VP1 during infection
of mock-treated cells (not treated with NH4Cl) at 2 and 4 h pi. De novo
synthesis of VP1 protein in progeny viruses at 4 h pi is shown as green
regions (FITC label). Alexa Fluor 594 (red) indicates clathrin. (B) Effects of
NH4Cl on the distribution and expression of CVB3 VP1. HeLa cells were
treated with NH4Cl (50 mM) before CVB3 infection, and NH4Cl levels
were maintained during and after infection. No synthesis of VP1 or progeny
viruses was observed even at 4 h pi. Compare with panel A images.
Internalized viruses were trapped in CCV, which are represented by yellow
spots (indicated by arrowheads). Green spots represent FITC-labeled VP1
and red spots represent Alexa-Fluor-568-labeled clathrin.
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sion (hsc70–HeLa cells) were generated with small-interfer-
ing RNAs (siRNA), and we verified that hsc70 RNA levels
were down-regulated in these cells (Fig. 3B). When infected
with CVB3, the infectivity of CVB3 in hsc70–HeLa cells
was lower than in control cells (HeLa cells transfected with
siRNA empty vector, pSilencerk 2.1), corresponding to the
reduction in hsc70 RNA levels (Fig. 3C). This suggests that
Hsc70 is critically involved in CVB3 endocytosis, and
therefore that CVB3 endocytosis is dependent upon the
CCV cycle.
CVB3 trafficking is significantly dependent on endosomal
acidification
Some viral endocytosis is dependent on the low-pH-
mediated conformational changes that trigger fusion,
penetration, or uncoating (Sieczkarski and Whittaker,
2002). To determine whether CVB3 is dependent upon
low pH in trafficking in cytosol, we treated cells with
NH4Cl before viral infection. NH4Cl is a lysosomotropic
agent that causes a rapid rise in the pH of intracellular
organelles including endosomes, inhibiting low-pH-
dependent cellular processes such as endosomal fusion.
Therefore, NH4Cl has been used broadly to study the
endosomal acidification for endocytosis/trafficking (Nicola
et al., 2003; Ohkuma and Poole, 1978). In the NH4Cl
inhibition test, cells were pretreated with the concen-
tration of NH4Cl (50 mM) for 30 min prior to infection
with CVB3 at a moi of 10. At 4 h pi, the expression of
viral proteins for progeny assembly was clearly apparent
in mock cells (Fig. 4A, represented by FITC-stained
green regions). However, there was no expression of new
viral proteins in NH4Cl-treated cells, whereas a few viral
particles were trapped in CCV during NH4Cl treatment
(Fig. 4B, represented by yellow spots indicated with
arrowheads; VP1 represented by green spots, clathrin
represented by red spots). This suggests that the fusion of
CCV and early endosomes is dependent on low pH.
Based on the above data (Fig. 4), CVB3 trafficking in
cytosol after entry is significantly dependent on low-pH
environments in cellular organelles.
Internalized CVB3 is transcytosed to endosomes
The results described above (Fig. 4), showing that the
maintenance of a low pH in cellular organelles, such as
endosomes, is critical, indicates that endosomes are
physically involved in CVB3 endocytosis. To confirm
this, we stained CVB3 particles with anti-VP1 antibody
and endosomes with antibody directed against EEA1, a
cytosolic protein that may be associated with early
endosomal membranes and that is involved in endo-
some–endosome tethering and fusion (Simonsen et al.,
1998), in infected HeLa cells and followed the signals
over time. CVB3 particles clearly colocalized with earlyendosomes (Fig. 5, represented by yellow spots indicated
with arrowheads). We identified some colocalizing yellow
spots at 1.5 h pi and 3 h pi (Fig. 5), indicating that the
Fig. 5. Internalized CVB3 is transcytosed to early endosomes. Colocaliza-
tion of VP1 and EEA1 is indicated by arrowheads. CVB3 VP1 is
represented by FITC label (green spots). Alexa Fluor 594 label (red spots)
represents EEA1.
S.-K. Chung et al. / Virology 333 (2005) 31–40 37CCV containing internalized CVB3 particles fused with
early endosomes.Discussion
It is generally accepted that once delivered to early
endosomes, recycling receptors are returned to the cell
surface, in contrast to down-regulated receptors, which are
transported to late endosomes and thence to lysosomes
(Gruenberg and Maxfield, 1995). Our initial experiments
described here (Fig. 1) show the role of CAR in CVB3
endocytosis. CVB3 interacts with CAR to cross the plasma
membrane. CAR is internalized with CVB3 particles and
does not return to the cell surface via recycling endosomes as
some other cellular receptors do, such as the GPI-anchored
protein, DAF (Gruenberg and Maxfield, 1995; Sabharanjak
et al., 2002). In these experiments, we could exclude the
possibility in which CVB3 masks CAR molecules on the cell
surface to block the binding of anti-CAR to CAR because
CVB3 clearly crosses the plasma membrane and is present
inside cells less than 10 min pi (as shown in Fig. 2) and the
trypsin treatment before immunostaining for FACS analysis
dissociated the binding remained CVB3 particles and cellular
receptor on cell surface. Therefore, the above data (Fig. 1)
strongly suggest that CAR acts as a major receptor interacting
with CVB3 on the cell surface and that this interacting
complex is invaginated in CCV. The internalized CAR is not
recycled to the cell surface.
Here we used Western blotting to detect viral protein
expression in infected cells. To confirm whether the Westernblot data could represent a productive infection, we infected
with UV-inactivated virus and activated virus (100 moi) for
1 h and washed with PBS. Then we performed Western
blotting with anti-VP1 at 4 h and 6 h pi. UV-inactivated
virus infection did not show any VP1 band (data not
shown). Therefore, it is possible that Western blot detection
represents viral infection and expression.
Visual images provided by confocal microscopy and EM
analysis show that the internalized CVB3 particles are
clearly present in CCV (Fig. 2). To confirm it, we explored
whether some endocytosis-related factors play a role in the
internalization and trafficking of CVB3, especially clathrin-
mediated endocytosis, over a sequential time course. When
clathrin-coated pits (CCP) become CCV, dynamin functions
to cut the neck of the CCP to form CCV; it also acts in this
capacity in the formation of caveolae (Damke et al., 1994;
Oh et al., 1998). Here, the infectivity of CVB3 was reduced
in K44A cells containing in a dynamin mutant (Fig. 3A),
suggesting that the entry of CVB3 requires an intact
dynamin function and that the entry of CVB3 is mediated
by endocytosis, and not by direct delivery of the viral
genome on the cell surface.
The data described above demonstrate that the internal-
ized CVB3 particles are present in CCV. The fusion of
these CCV with early endosomes requires clathrin uncoat-
ing of the CCV, which is regulated by Hsc70 activity
(Chang et al., 2002; Newmyer et al., 2003). Therefore, the
Hsc70 requirement for CVB3 infection, based on Fig. 3C,
supports the proposition that CVB3 is internalized by
clathrin-mediated endocytosis. Moreover, as we show in
Fig. 4, in CVB3 infection, the acidic environments of
cellular organelles are critically necessary for the fusion of
CCV to early endosomes and for the fusion of endosomes
to endosomes, as has been described for adenovirus and
herpes simplex virus (Da Costa et al., 2003; Meier and
Greber, 2003; Nicola et al., 2003). Finally, we clearly
confirmed that internalized CVB3 colocalizes with EEA1,
which is associated with early endosomes (Fig. 5). These
results strongly suggest that the internalized CVB3
particles are transcytosed to early endosomes.
Very recently, Triantafilou and Triantafilou (2004)
reported that CVB4, which is implicated in the development
of insulin-dependent diabetes mellitus (Horwitz, 1990), is
endocytosed independently of clathrin-associated machinery
and is delivered to the Golgi via a lipid-raft-dependent
mechanism. Actually, strain-specific differences of CVB1-6
including the interaction of CVBs with CAR and DAF, and
the cytopathic effects in several cell types, have been well
studied (Selinka et al., 2002; Schmidtke et al., 2000; Pasch
et al., 1999). Furthermore, the extensive differences of
interaction with CAR and DAF could occur even within the
same serotype group of CVB3 and these differences may
have a role in the different virulent phenotypes of the CVB3
strains (Selinka et al., 2002; Schmidtke et al., 2000).
Previously, it has been published that anti-DAF blocked
infection with CVB1 (Conn-5), CVB3 (Nancy), and CVB5
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CVB strains (Bergelson et al., 1997; Wang and Bergelson,
1999). However, the entry of CVB3 H3 strain, originating
from the Woodruff variant, is dependent on CAR, but not
DAF (Fig. 1). Therefore, it is possible that the endocytotic
mechanism of CVB3 (H3) and CVB4 (Edwards strain 2,
E2) could be distinct. These differences of endocytosis
mechanism in the same viral strains are also found in human
papilloma viruses (HPVs) where HPV-16 and -58 used
clathrin-dependent endocytosis while HPV-31 used caveo-
lae-dependent endocytosis (Bousarghin et al., 2003).
In here, we used the visual images, which were achieved
by confocal microscopy and EM, and the mutants or
chemical inhibition of several cellular factors, which were
related with endocytosis to explore the viral internalization
and trafficking, although some is not shown directly.
However, because all factors tested in this study were
previously reported the relation with endocytosis and all
data were complementary for each other, it is clear to
determine the endocytosis mechanism of CVB3.
Based on these results taken together, we propose an
endocytic model for CVB3 H3 Woodruff variant, in which
CVB3 is internalized, after binding to the receptor CAR,
and is involved with clathrin. The internalized CVB3
particles in CCV are then transcytosed into early endosomes
by a trafficking process.Materials and methods
Cells and virus
The cervical cancer cell line HeLa–UVM and Chinese
hamster ovary (CHO) were maintained in Dulbecco’s
modified Eagle’s medium (DMEM) supplemented with
10% fetal bovine serum (FBS). The HeLa–UVM cell line
(referred to herein as HeLa cells) was obtained from Sally
Huber (University of Vermont, USA). CVB3, which is an
H3 strain (Woodruff variant; the generous gift of E. Jeon,
Samsung Medical Center, Korea; Knowlton et al., 1996),
was grown and titered using HeLa cells. Viral stocks were
prepared by infecting 90% confluent cultures of HeLa
cells at a multiplicity of infection (moi) of 10. After
incubation for 16 h at 37 8C, the suspension was freeze-
thawed three times. The cell lysates were centrifuged, and
the supernatants were harvested and stored at 75 8C.
The virus titer was measured by plaque assay. The titer of
CVB3 H3 was 1  109 plaque-forming units (pfu)/ml. A
stock of radioactively labeled CVB3 was prepared as
previously described (Zaragoza et al., 1997). The pellet
was resuspended in phosphate-buffered saline (PBS) and
the viral titer was measured. The labeled viral stock used
in this work had a titer of 2  108 pfu/ml. HeLa cells
stably expressing mutant dynamin (K44A) or wild-type
dynamin were kindly supplied by K. Ahn (Division of
Life Science and Graduate School of Biotechnology,Korea University, Korea). The cells were cultured in
DMEM supplemented with 10% FBS, 400 Ag/ml G418
(Life Technologies, Inc.), 200 ng/ml puromycin, and 1
Ag/ml tetracycline. Cells were subcultured in six-well
plates. For induction, cells were grown in the absence of
tetracycline for 48 h at 37 8C before use. The cells were
grown to 80% confluence.
Antibodies and reagents
Anti-CAR antibody (clone RmcB) directed against
hCAR was purchased from Upstate Biotech. Mouse mono-
clonal antibody directed against human DAF (CD55; mAb
DAF) was from BD Pharmingen. Mouse mAb ncl-entero
(anti-VP1) against an epitope on the VP1 peptide was
obtained from Novocastra Laboratories. Anti-CHC (anti-
clathrin) monoclonal antibody was obtained from BD
Pharmingen. Rabbit polyclonal antibody directed against
caveolin-1 was also obtained from BD Pharmingen. Rabbit
polyclonal antibody directed against EEA1 was obtained
from Abcam. Anti-mouse IgG-fluorescein isothiocyanate
(FITC) and anti-rabbit IgG-FITC were purchased from
Santa Cruz Biotechnology. Alexa-Fluor-594-conjugated
mouse IgG and rabbit IgG were obtained from Molecular
Probes Inc. Alexa-Fluor-594-phalloidin (anti-actin) was
obtained from Molecular Probes Inc.
Flow-cytometric analysis
After viral infection, cells were harvested in trypsin-
EDTA, pooled, and resuspended in fresh medium (DMEM)
supplemented with 10% FBS. After brief centrifugation
(340 g) for 5min at 4 8C, the supernatant was discarded and
the cells were washed in PBS containing 1% BSA (PBA).
The cells were resuspended with primary antibody (1:100)
and incubated on ice for 60 min. Cell pellets were then
washed in PBA and incubated with mouse IgG-FITC (1:200)
for 40 min. The cells were washed twice more with PBS. The
expression of CAR and DAF in suspended cell samples was
directly determined using a FACSCalibur cytometer (Becton
Dickinson). Ten thousand fluorescent events per sample were
acquired using a 530/15 band-pass filter for the FITC signal
with fluorescence emission centered at 530 nm.
Immunofluorescence
In the presence or absence of inhibitor, 60% confluent
monolayers of HeLa cells were grown on glass coverslips.
The cells were then infected at a moi of N100 CVB3 at
37 8C for various times. The cells on glass coverslips
were fixed with 4% paraformaldehyde for 15 min,
quenched with 50 mM NH4Cl for 10 min, and then
permeabilized with 0.1% Triton X-100 in PBS for 5 min.
Cells were washed, blocked with PBA (containing 2%
BSA), and incubated with primary antibody (1:50–1:100
dilution) for 40 min. After this time, the coverslips were
S.-K. Chung et al. / Virology 333 (2005) 31–40 39washed three times with PBA and then incubated for 30
min with Alexa Fluor 488 or Alexa Fluor 594 (1:100;
Molecular Probes Inc.). The coverslips were then washed
three times and mounted onto glass slides with fluorescent
mounting medium (Dako Corp.). Images of cells were
viewed using a Bio-Rad LaserSharp confocal microscope.
Electron microscopy
Confluent cells were cultured in six-well plates (Nunc).
Infection with CVB3 was performed at a moi of 100. At
different time points (5 and 15 min) after infection, cells
were fixed in 4% paraformaldehyde in 0.1 M phosphate
buffer (PB; pH 7.4), for 20 min at 4 8C. Following
fixation, the cells were washed three times with 0.01 M
phosphate-buffered saline (PBS; pH 7.4). They were
incubated in 10% normal goat serum (NGS) in PBS for
1 h at room temperature, to block nonspecific binding, and
were then incubated in anti-clathrin (anti-CHC) sera for 12
h at 4 8C. The cells were washed in PBS for 45 min (3 
15 min), incubated in biotin-labeled goat anti-mouse
(Jackson Immuno Research; dilution 1:100) for 1 h, and
then washed three times in PBS for 45 min (3  15 min).
The cells were then incubated in avidin–biotin–peroxidase
complex (ABC) solution (Vector Laboratories, Burlingame,
CA) for 1 h, washed in TB, and then preincubated in
0.05% 3,3V-diaminobenzidine tetrahydrochloride (DAB) in
0.1 M Tris buffer for 10 min and incubated in the same
solution containing 0.05% hydrogen peroxide (H2O2) for
an additional 10 min. Stained sections were post-fixed in
1% glutaraldehyde in PB for 1 h and, after washing in PB
containing 4.5% sucrose for 15 min (3  5 min), they
were post-fixed in 1% osmium tetroxide (OsO4) in PB for
1 h. Afterwards they were rewashed in PB containing
4.5% sucrose and dehydrated in a graded series of alcohol.
During the dehydration procedure, they were stained with
1% uranyl acetate in 70% alcohol for 1 h, then transferred
to propylene oxide, and embedded in Epon 812. After
curing at 60 8C for 3 days, the Epon blocks were cut out
and attached to an Epon support for further ultrathin
sectioning (Reichert-Jung, Nuaˆloch, Germany). Ultrathin
sections (70–90 nm thick) were collected on one-hole grids
coated with Formvar and examined using an electron
microscope (Jeol 1200EX, Tokyo, Japan).
Western blotting
Cells infected by virus in the absence or presence of
various chemicals were washed with ice-cold Dulbecco’s
phosphate-buffered saline and lysed in lysis buffer, as
described above, containing 1  Protease Inhibitor Mixture
(Roche Applied Science). Protein concentrations were
determined with a BCA Assay Kit (Sigma). Equal quantities
of protein (30 Ag) were separated by 10% sodium dodecyl
sulfate–polyacrylamide gel electrophoresis (SDS–PAGE)
under reducing conditions and then electrophoreticallytransferred onto nitrocellulose membranes. The blots were
then probed with the appropriate antibody directed against
VP1 (1:1000), hCAR (1:500), or EEA1 (1:1000), followed
by incubation with the corresponding secondary antibody,
and visualization with ECL reagents (Perbio).
Construction of small interfering RNA (siRNA) for hsc70
The target sequence for hsc70 siRNA is as follows: 5V-
GATCCGTCGAGATAATTGCCAATGTTCAAGAGA-
CATTGGCAATTATCTCGACTTTTTTGGAAA-3V. The
underlined sequence represents the target regions of hsc70
mRNA. This siRNA was cloned downstream from the
human U6 promoter as described in the pSilencerk 2.1-U6
hygro manual (Ambion). For transfection, cells were plated
onto dishes at 70–80% confluence without antibiotics. This
plasmid construct was transfected into HeLa cells at a
concentration of 400 ng siRNA per 35 mm dish with
Lipofectamine Reagent (Invitrogen), as directed by the
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